High scores for the strongly correlated Treg populations estimated by IHC of FOXP3 and CD4/CD25/FOXP3 were both associated with a higher 5-year RFS rate among patients with stage I-III CRC in Norwegian Series 2 (Supplementary Fig. 14A). Here, FOXP3 is linked to colorectal carcinoma.